Impact of Early Graft Function on 10-Year Graft Survival in Recipients of Kidneys From Standard- or Expanded-Criteria Donors

2013 ◽  
Vol 96 (2) ◽  
pp. 176-181 ◽  
Author(s):  
Nassima Smail ◽  
Jean Tchervenkov ◽  
Steven Paraskevas ◽  
Dana Baran ◽  
Istvan Mucsi ◽  
...  
2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Karol Graňák ◽  
Vnuäã¡k Matej ◽  
Petra Skálová ◽  
Juraj Miklušica ◽  
Ľudovít Laca ◽  
...  

Abstract Background and Aims Kidneys from expanded criteria donors with diagnosis of brain death have become a part of the organ transplant program, which have thus increased the number of transplants. Method In this retrospective analysis, we identified the expanded criteria donors in a group of 156 kidney donors at our center. Basic parameters of the donors before kidney recovery were collected. Graft function, graft survival, and patient survival at 1, 3, and 5 years posttransplant were compared in expanded criteria versus standard criteria donors. Results Expanded criteria donors were significantly older than standard criteria donors (P < .001), had higher body mass index (P = .006), and had more frequent arterial hypertension (P < .001) and diabetes mellitus (P = .004) in their histories. When we considered the estimated glomerular filtration rate, graft function in the first 6 months after transplant was significantly worse in kidneys from expanded criteria donors (P = .011). In addition, recipients of grafts from expanded criteria donors had significantly worse survival in the first year posttransplant (P = .023); however, no differences in graft survival were observed. Conclusion From the long-term aspect, graft function and graft and patient survival in cases of kidneys from expanded criteria donors were comparable to results with kidneys from standard criteria donors. Expanded use of organs available for transplant is important due to the constantly increasing demands versus limited offers of organs.


2021 ◽  
Vol 79 ◽  
pp. S485-S486
Author(s):  
M.R. Peradejordi Font ◽  
A. Vilaseca Cabo ◽  
L. Peri Cusi ◽  
M. Musquera Felip ◽  
T. Ajami Fardoun ◽  
...  

1999 ◽  
Vol 12 (5) ◽  
pp. 378-382 ◽  
Author(s):  
Ben O'Mar Arrington ◽  
Milan Kinkhabwala ◽  
M. M. R. Polyak ◽  
Sandip Kapur ◽  
William T. Stubenbord

ASAIO Journal ◽  
1998 ◽  
Vol 44 (5) ◽  
pp. M610-M612 ◽  
Author(s):  
Maximilian M.R. Polyak ◽  
BenÓmar Arrington ◽  
William T. Stubenbord ◽  
Milan Kinkhabwala

2017 ◽  
Vol 26 (2) ◽  
pp. 319-326 ◽  
Author(s):  
Kevin V. Chow ◽  
Emma M. Carrington ◽  
Yifan Zhan ◽  
Andrew M. Lew ◽  
Robyn M. Sutherland

Islet transplantation can cure type 1 diabetes but is limited by lack of donor organs and early graft dysfunction, such that many patients require multiple transplants to achieve insulin independence. Monocyte-derived dendritic cells (moDCs) arise during inflammation and allograft encounters where they can promote various innate and adaptive immune responses. To determine whether moDCs impair early graft function following allogeneic islet transplantation, we transplanted MHC-mismatched BALB/c (H-2d) islets into diabetic C57BL/6-CCR2. DTR recipients (H-2b) treated with either saline (control) or diphtheria toxin (DT) to deplete moDCs. Graft function was assessed by blood glucose (BG) measurement. DT treatment resulted in specific depletion of graft site moDCs posttransplant. Despite equivalent pretransplant BG levels [27.0 ± 1.3 vs. 29.6 ± 1.1 mM, not significant (ns)], DT recipients achieved lower posttransplant BG levels and better rates of normoglycemia than control recipients (11.0 ± 1.9 vs. 19.1 ± 1.4 mM, p = 0.004) at 1 day posttransplant in diabetic recipients. When a suboptimal donor dose of 200 islets was transplanted, DT-induced moDC depletion resulted in normoglycemia in 78% compared to 25% of control recipients ( p = 0.03). As well as amelioration of graft dysfunction in the immediate peritransplant period, prolonged DT administration (15 days posttransplant) resulted in improved graft survival (21 vs. 11 days, p = 0.005). moDCs impair early graft function post-allogeneic islet transplantation. moDC depletion may allow for improved early graft function, permit transplantation with lower islet masses, and enhance graft survival.


Sign in / Sign up

Export Citation Format

Share Document